Literature DB >> 3469159

Diffusion of oral ofloxacin (HOE 280) into human prostatic tissue: assessment by an improved high-performance liquid chromatographic method.

R Claes, Y Dusart, J C Dupont, B Jeanbaptiste, M Podoor, J Douchamps.   

Abstract

11 patients with a prostatic adenoma received a single oral 200 mg dose of ofloxacin 2 h before transurethral resection of the prostate. During the operation, blood samples and prostatic tissue cuttings were collected simultaneously. Ofloxacin was assayed by an original HPLC method with UV detection. The mean concentration of the unchanged drug was 5.10 mg/kg wet tissue and 1.81 mg/l in prostatic tissue and plasma, respectively. The 3.17 prostate/plasma ratio reflected a good penetration of ofloxacin into the prostatic tissue.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3469159     DOI: 10.1007/BF01661289

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  13 in total

1.  Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue.

Authors:  G Montay; J P Tassel
Journal:  J Chromatogr       Date:  1985-04-12

2.  Pharmacokinetics of ofloxacin and theophylline alone and in combination.

Authors:  J B Fourtillan; J Granier; B Saint-Salvi; J Salmon; A Surjus; D Tremblay; M Vincent Du Laurier; S Beck
Journal:  Infection       Date:  1986       Impact factor: 3.553

3.  [Therapeutic effect of ofloxacin (DL 8280) on pulmonary tuberculosis. (Report of a one year-administration study on sixteen treatment-failure patients)].

Authors:  M Tsukamura; E Nakamura; S Yoshii; M Yanase; Y Yasuda; H Amano
Journal:  Kekkaku       Date:  1985-06

4.  High-performance liquid chromatographic procedure for the quantitation of norfloxacin in urine, serum and tissues.

Authors:  C Forchetti; D Flammini; G Carlucci; G Cavicchio; L Vaggi; M Bologna
Journal:  J Chromatogr       Date:  1984-07-13

5.  Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.

Authors:  G Seibert; M Limbert; N Klesel
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

6.  Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis.

Authors:  M Tsukamura; E Nakamura; S Yoshii; H Amano
Journal:  Am Rev Respir Dis       Date:  1985-03

7.  In vitro and in vivo activity of DL-8280, a new oxazine derivative.

Authors:  K Sato; Y Matsuura; M Inoue; T Une; Y Osada; H Ogawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

8.  [Diffusion of ofloxacin in human lung tissue].

Authors:  L Couraud; J B Fourtillan; M C Saux; A Bryskier; M Vincent du Laurier
Journal:  Infection       Date:  1986       Impact factor: 3.553

9.  Antituberculosis activity of ofloxacin (DL 8280) on experimental tuberculosis in mice.

Authors:  M Tsukamura
Journal:  Am Rev Respir Dis       Date:  1985-10

10.  In vitro antituberculosis activity of a new antibacterial substance ofloxacin (DL8280).

Authors:  M Tsukamura
Journal:  Am Rev Respir Dis       Date:  1985-03
View more
  3 in total

Review 1.  Ofloxacin clinical pharmacokinetics.

Authors:  K C Lamp; E M Bailey; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 2.  Diagnostic and therapeutic problems in prostatitis. Therapeutic position of ofloxacin.

Authors:  J Aagaard; P O Madsen
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

Review 3.  Use of quinolones in treatment of prostatitis and lower urinary tract infections.

Authors:  V T Andriole
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.